J Korean Diabetes.  2018 Dec;19(4):193-199. 10.4093/jkd.2018.19.4.193.

Effect of Nutrient Preload and Food Order on Glucose, Insulin, and Gut Hormones

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
  • 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. ymchomd@snu.ac.kr

Abstract

Postprandial hyperglycemia is associated with the risk of diabetes mellitus, cardiovascular disease, and mortality. Nutrition therapy is an important component of the management of postprandial hyperglycemia. Postprandial glucose levels are determined by several factors, such as the quantity and composition of nutrients, gastric emptying rates, secretion of incretin hormones, insulin secretion, glucose uptake by peripheral tissues, and endogenous glucose production. Nutrient preload and food order (or meal sequence) are dietary approaches targeting these factors. Nutrient preload reduces postprandial glucose excursion by enhancing insulin secretion, augmenting the secretion of glucagonlike peptide-1, and delaying gastric emptying. Carbohydrates-last food order improves glycemic control, increases the secretion of glucagon-like peptide-1, and decreases insulin requirements. Therefore, both nutrient preload and manipulation of food order can be an effective, safe, and feasible strategy for treating hyperglycemia in individuals with diabetes mellitus.

Keyword

Carbohydrates; Diabetes mellitus; Food; Gastrointestinal hormones; Glucagon-like peptide-1; Incretins; Insulin; Meals; Postprandial hyperglycemia; Whey proteins

MeSH Terms

Carbohydrates
Cardiovascular Diseases
Diabetes Mellitus
Gastric Emptying
Gastrointestinal Hormones
Glucagon-Like Peptide 1
Glucose*
Hyperglycemia
Incretins
Insulin*
Meals
Mortality
Nutrition Therapy
Whey Proteins
Carbohydrates
Gastrointestinal Hormones
Glucagon-Like Peptide 1
Glucose
Incretins
Insulin
Whey Proteins

Reference

1. Korean Diabetes Association. Treatment guideline for diabetes. 5th ed. Seoul: Korean Diabetes Association;2015. p. 31–37.
2. American Diabetes Association. 4. Lifestyle management: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018; 41:Suppl 1. S38–S50.
3. Franz MJ, MacLeod J, Evert A, Brown C, Gradwell E, Handu D, Reppert A, Robinson M. Academy of nutrition and dietetics nutrition practice guideline for type 1 and type 2 diabetes in adults: systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J Acad Nutr Diet. 2017; 117:1659–1679.
Article
4. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criter ia. The DECODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet. 1999; 354:617–621.
5. Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, Iwamoto Y, Tajima N. International Diabetes Epidemiology Group. DECODA Study Group. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia. 2000; 43:1470–1475.
Article
6. Donahue RP, Abbott RD, Reed DM, Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes. 1987; 36:689–692.
Article
7. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care. 1998; 21:1236–1239.
Article
8. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999; 22:920–924.
Article
9. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002; 359:2072–2077.
Article
10. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003; 290:486–494.
Article
11. Brubaker PL, Ohayon EL, D'Alessandro LM, Norwich KH. A mathematical model of the oral glucose tolerance test illustrating the effects of the incretins. Ann Biomed Eng. 2007; 35:1286–1300.
Article
12. Holst JJ, Gribble F, Horowitz M, Rayner CK. Roles of the gut in glucose homeostasis. Diabetes Care. 2016; 39:884–892.
Article
13. Schwartz SS, Epstein S, Corkey BE, Grant SF, Gavin JR 3rd, Aguilar RB. The time is right for a new classification system for diabetes: rationale and implications of the β-cell-centric classification schema. Diabetes Care. 2016; 39:179–186.
Article
14. Gannon MC, Nuttall FQ, Krezowski PA, Billington CJ, Parker S. The serum insulin and plasma glucose responses to milk and fruit products in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1986; 29:784–791.
Article
15. Nilsson M, Stenberg M, Frid AH, Holst JJ, Björck IM. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr. 2004; 80:1246–1253.
Article
16. Frid AH, Nilsson M, Holst JJ, Björck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr. 2005; 82:69–75.
Article
17. Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones KL, Clifton PM, Horowitz M, Rayner CK. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care. 2009; 32:1600–1602.
Article
18. Jakubowicz D, Froy O, Ahrén B, Boaz M, Landau Z, Bar-Dayan Y, Ganz T, Barnea M, Wainstein J. Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial. Diabetologia. 2014; 57:1807–1811.
Article
19. Wu T, Little TJ, Bound MJ, Borg M, Zhang X, Deacon CF, Horowitz M, Jones KL, Rayner CK. A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetes. Diabetes Care. 2016; 39:511–517.
Article
20. Gribble FM, Manley SE, Levy JC. Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166). Diabetes Care. 2001; 24:1221–1225.
Article
21. Kitabchi AE, Kaminska E, Fisher JN, Sherman A, Pitts K, Bush A, Bryer-Ash M. Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus. Am J Med Sci. 2000; 319:143–148.
Article
22. Cozma LS, Luzio SD, Dunseath GJ, Langendorg KW, Pieber T, Owens DR. Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal. Diabetes Care. 2002; 25:1271–1276.
Article
23. Paterson MA, Smart CE, Lopez PE, McElduff P, Attia J, Morbey C, King BR. Influence of dietary protein on postprandial blood glucose levels in individuals with Type 1 diabetes mellitus using intensive insulin therapy. Diabet Med. 2016; 33:592–598.
Article
24. Li L, Xu J, Zhu W, Fan R, Bai Q, Huang C, Liu J, Li Z, Sederholm M, Norstedt G, Wang J. Effect of a macronutrient preload on blood glucose level and pregnancy outcome in gestational diabetes. J Clin Transl Endocrinol. 2016; 5:36–41.
Article
25. Akhavan T, Luhovyy BL, Brown PH, Cho CE, Anderson GH. Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. Am J Clin Nutr. 2010; 91:966–975.
Article
26. Gunnerud UJ, Ostman EM, Björck IM. Effects of whey proteins on glycaemia and insulinaemia to an oral glucose load in healthy adults; a dose-response study. Eur J Clin Nutr. 2013; 67:749–753.
Article
27. Akhavan T, Luhovyy BL, Panahi S, Kubant R, Brown PH, Anderson GH. Mechanism of action of pre-meal consumption of whey protein on glycemic control in young adults. J Nutr Biochem. 2014; 25:36–43.
Article
28. Gunnerud UJ, Heinzle C, Holst JJ, Östman EM, Björck IM. Effects of pre-meal drinks with protein and amino acids on glycemic and metabolic responses at a subsequent composite meal. PLoS One. 2012; 7:e44731.
Article
29. Dougkas A, Östman E. Protein-enriched liquid preloads varying in macronutrient content modulate appetite and appetite-regulating hormones in healthy adults. J Nutr. 2016; 146:637–645.
Article
30. Tricò D, Baldi S, Tulipani A, Frascerra S, Macedo MP, Mari A, Ferrannini E, Natali A. Mechanisms through which a small protein and lipid preload improves glucose tolerance. Diabetologia. 2015; 58:2503–2512.
Article
31. Ma J, Jesudason DR, Stevens JE, Keogh JB, Jones KL, Clifton PM, Horowitz M, Rayner CK. Sustained effects of a protein ‘preload’ on glycaemia and gastric emptying over 4 weeks in patients with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract. 2015; 108:e31–e34.
Article
32. Mingnone LE, Wu T, Phillips LK, Bound MJ, Checklin H, Grivell J, Jones KL, Clifton PM, Horowitz M, Rayner CK. A whey/guar “preload” improves postprandial glycaemia and HbA1c in type 2 diabetes: a 12-week, single-blind, randomised and placebo controlled trial. Paper presented at: The 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD). 2016 Sep 12-16; Munich, Germany. p. S9.
33. Kim EK, Oh TJ, Kim LK, Cho YM. Improving effect of the acute administration of dietary fiber-enriched cereals on blood glucose levels and gut hormone secretion. J Korean Med Sci. 2016; 31:222–230.
Article
34. Bae JH, Kim LK, Min SH, Ahn CH, Cho YM. Postprandial glucose-lowering effect of premeal consumption of protein-enriched, dietary fiber-fortified bar in individuals with type 2 diabetes mellitus or normal glucose tolerance. J Diabetes Investig. 2018; 9:1110–1118.
Article
35. Sheard NF, Clark NG, Brand-Miller JC, Franz MJ, Pi-Sunyer FX, Mayer-Davis E, Kulkarni K, Geil P. Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association. Diabetes Care. 2004; 27:2266–2271.
Article
36. Shukla AP, Iliescu RG, Thomas CE, Aronne LJ. Food order has a significant impact on postprandial glucose and insulin levels. Diabetes Care. 2015; 38:e98–e99.
Article
37. Shukla AP, Andono J, Touhamy SH, Casper A, Iliescu RG, Mauer E, Shan Zhu Y, Ludwig DS, Aronne LJ. Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes. BMJ Open Diabetes Res Care. 2017; 5:e000440.
Article
38. Kuwata H, Iwasaki M, Shimizu S, Minami K, Maeda H, Seino S, Nakada K, Nosaka C, Murotani K, Kurose T, Seino Y, Yabe D. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial. Diabetologia. 2016; 59:453–461.
Article
39. Shukla AP, Dickison M, Coughlin N, Karan A, Mauer E, Truong W, Casper A, Emiliano AB, Kumar RB, Saunders KH, Igel LI, Aronne LJ. The impact of food order on postprandial glycaemic excursions in prediabetes. Diabetes Obes Metab. 2018; DOI: 10.1111/dom.13503. [Epub ahead of print].
Article
40. Faber EM, van Kampen PM, Clement-de Boers A, Houdijk EC, van der Kaay DC. The influence of food order on postprandial glucose levels in children with type 1 diabetes. Pediatr Diabetes. 2018; 19:809–815.
Article
41. Tricò D, Filice E, Trifirò S, Natali A. Manipulating the sequence of food ingestion improves glycemic control in type 2 diabetic patients under free-living conditions. Nutr Diabetes. 2016; 6:e226.
Article
42. Imai S, Fukui M, Kajiyama S. Effect of eating vegetables before carbohydrates on glucose excursions in patients with type 2 diabetes. J Clin Biochem Nutr. 2014; 54:7–11.
Article
Full Text Links
  • JKD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr